Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BTD-001 in Idiopathic Hypersomnia or Narcolepsy Type 2
NCT02512588Phase 2Completed
- Sponsor
- Balance Therapeutics, Inc.
- Start
- Sep 2015
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Pentetrazol in idiopathic hypersomnia (IH), narcolepsy type 2 (NT2), sponsored by Balance Therapeutics, Inc.. Started Sep 2015; status: completed.
02
Drugs
Pentetrazol
03
Conditions
idiopathic hypersomnia (IH)narcolepsy type 2 (NT2)
Beyond the preview
Go deeper on NCT02512588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02512588.